Nanjing Leads Biolabs and Aditum Bio Launch Oblenio Bio with Focus on CD19 Tri-Specific Antibody
China-based Nanjing Leads Biolabs Co., Ltd and venture capital firm Aditum Bio have announced the...
Sanofi and Cathay Capital Forge Partnership to Boost Sino-French Pharmaceutical Cooperation
French pharmaceutical giant Sanofi (NASDAQ: SNY) has signed a partnership deal with Cathay Capital, a...
Eisai and GE Healthcare Sign MoU at CIIE to Collaborate on Alzheimer’s Disease Solutions
At the 7th China International Import Expo (CIIE), Japan-based Eisai Co., Ltd (TYO: 4523) entered...
Lohmann & Rauscher Partners with Allmed Medical Products at CIIE for Medical Dressings
Lohmann & Rauscher, a medical group with headquarters in Germany and Austria, has entered into...
I-Mab Appoints Sean (Xi-Yong) Fu as Permanent CEO, Effective November 1, 2024
US-based biopharmaceutical company I-Mab (NASDAQ: IMAB) has announced the appointment of Sean (Xi-Yong) Fu, PhD,...
Novo Nordisk Reports Q3 2024 Financials with 24% YOY Revenue Growth
Denmark-based pharmaceutical company Novo Nordisk A/S (NYSE: NVO) has released its financial results for the...
Shanghai Pharmaceutical Co., Ltd Secures Multiple Partnerships at CIIE
At the 7th China International Import Expo (CIIE), China-based Shanghai Pharmaceutical Co., Ltd (SPH, SHA:...
Siemens Healthineers AG Reports Fiscal 2024 Results with Targeted Revenue Growth
Germany-based medical device giant Siemens Healthineers AG (ETR: SHL) has released its financial results for...
HutchMed to Present Updated Data from Solvleplenib ESLIM-01 Phase III Trial at ASH and ESMO Congress 2024
China-based HutchMed (China) Ltd (NASDAQ: HCM; HKG: 0013) has announced plans to present new and...
Bayer HealthCare Partners with China Population Welfare Foundation at CIIE for Public Health Initiatives
German pharmaceutical giant Bayer HealthCare (FRA: BAYN) has entered into a partnership agreement with the...
Medtronic Partners with China Resources Guangdong Pharmaceutical at CIIE for Medical Equipment Development
US-Irish firm Medtronic (NYSE: MDT) has entered into a partnership with China-based China Resources Guangdong...
Pfizer’s Talzenna (talazoparib) Approved by China’s NMPA for mCRPC Treatment
The National Medical Products Administration (NMPA) website has indicated that Pfizer’s (NYSE: PFE) marketing filing...
Shouyao Holdings Adjusts Development Strategy for SY-1530, Halts Monotherapy Clinical Trials
Beijing-based Shouyao Holdings (Beijing) Co., Ltd (SHA: 688197) has announced a strategic adjustment regarding its...
Nanjing Leads Biolabs Secures FDA Orphan Drug Designation for LBL-034 in Multiple Myeloma Treatment
Nanjing Leads Biolabs Co., Ltd, a China-based biopharmaceutical company, has announced that it has received...
Sanofi’s Dupixent Gains EMA Approval for Eosinophilic Esophagitis in Children
French pharmaceutical giant Sanofi (NASDAQ: SNY) has announced that it has received marketing approval from...
Novartis Forges Partnerships at CIIE to Strengthen Radioligand Therapy Ecosystem in China
At the 7th China International Import Expo (CIIE), Swiss pharmaceutical giant Novartis (NYSE: NVS) announced...
China’s NHC Announces Initiative to Boost Gerontology Medical Services
The National Health Commission (NHC) has issued a notification aimed at enhancing gerontology medical service...
Vantive Secures Collaborations with Kertone and Qiantang Longyue at CIIE for Dialysis Solutions
Vantive, a planned spin-off from U.S.-based Baxter International (NYSE: BAX) specializing in kidney care, has...
Amgen’s Tavneos Receives NMPA Approval for ANCA-Associated Vasculitis Treatment in China
US biotechnology company Amgen (NASDAQ: AMGN) has announced that it has received market approval in...
Boston Scientific Launches Vercisie Genius DBS System in China for Parkinson’s Disease Treatment
US major Boston Scientific Corporation (NYSE: BSX) has officially launched its Vercisie Genius, an implantable...